COVID-19-associated thyroid diseases: Difference between revisions
| Line 30: | Line 30: | ||
==Diagnosis== | ==Diagnosis== | ||
===Diagnostic Study of Choice=== | ===Diagnostic Study of Choice=== | ||
The diagnosis of COVID-19-associated thyroid diseases is made based on the [[thyroid function test]] ([[TFT]]), which measures serum levels of [[triiodothyronine]] ([[T3]]), [[thyroxine]] ([[T4]]), and [[thyroid stimulating hormone]] ([[TSH]]). | |||
===History and Symptoms=== | ===History and Symptoms=== | ||
Revision as of 14:21, 14 July 2022
Template:COVID-19 thyroid disorders
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
COVID-19 has been found to affect several organs and body systems, including the endocrine system, with short-term and possible long-term consequences.
Historical Perspective
Classification
There is no established system for the classification of COVID-19-associated thyroid disorders.
Pathophysiology
Causes
Differentiating ((Page name)) from other Diseases
Epidemiology and Demographics
Risk Factors
There are no established risk factors for COVID-19-associated [[[thyroid diseases]].
Screening
There is insufficient evidence to recommend routine screening for COVID-19-associated thyroid diseases.
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
The diagnosis of COVID-19-associated thyroid diseases is made based on the thyroid function test (TFT), which measures serum levels of triiodothyronine (T3), thyroxine (T4), and thyroid stimulating hormone (TSH).
History and Symptoms
Physical Examination
Laboratory Findings
X-ray
There are no x-ray findings associated with COVID-19-associated thyroid diseases.